BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 27081112)

  • 1. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
    Patel VB; Zhong JC; Grant MB; Oudit GY
    Circ Res; 2016 Apr; 118(8):1313-26. PubMed ID: 27081112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure.
    Patel VB; Lezutekong JN; Chen X; Oudit GY
    Can J Cardiol; 2017 Jul; 33(7):943-946. PubMed ID: 28279521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
    Yu J; Wu Y; Zhang Y; Zhang L; Ma Q; Luo X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):738-746. PubMed ID: 30124209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
    Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
    Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of ACE2-Ang 1-7-Mas axis on blood vessel].
    Liu CQ; Huang Y; Lu LM
    Sheng Li Ke Xue Jin Zhan; 2007 Jan; 38(1):43-8. PubMed ID: 17438952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE2: a new target for cardiovascular disease therapeutics.
    Raizada MK; Ferreira AJ
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
    Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
    Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ACE2 in diastolic and systolic heart failure.
    Wang W; Bodiga S; Das SK; Lo J; Patel V; Oudit GY
    Heart Fail Rev; 2012 Sep; 17(4-5):683-91. PubMed ID: 21638102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.
    Oudit GY; Penninger JM
    Curr Heart Fail Rep; 2011 Sep; 8(3):176-83. PubMed ID: 21611889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
    Keidar S; Kaplan M; Gamliel-Lazarovich A
    Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.
    Rabelo LA; Alenina N; Bader M
    Hypertens Res; 2011 Feb; 34(2):154-60. PubMed ID: 21124322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
    Xu P; Sriramula S; Lazartigues E
    Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R804-17. PubMed ID: 21178125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
    Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl
    Li XY; Peng Y; Bu XW; Yao J; Yao L
    Chin J Integr Med; 2018 Nov; 24(11):853-859. PubMed ID: 29335866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2: more of Ang-(1-7) or less Ang II?
    Ferrario CM
    Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):1-6. PubMed ID: 21045683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?
    Gromotowicz-Poplawska A; Szoka P; Kolodziejczyk P; Kramkowski K; Wojewodzka-Zelezniakowicz M; Chabielska E
    Exp Biol Med (Maywood); 2016 Nov; 241(17):1888-1899. PubMed ID: 27439538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-(1-7): beyond the cardio-renal actions.
    Passos-Silva DG; Verano-Braga T; Santos RA
    Clin Sci (Lond); 2013 Apr; 124(7):443-56. PubMed ID: 23249272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.